Skip to main content
. 2017 Feb 10;96(6):e6056. doi: 10.1097/MD.0000000000006056

Figure 1.

Figure 1

Photographs of the patient's soles. (A) At admission, the patient's soles exhibited purpura that extended to the tips, with tenderness; the purpura worsened before the eculizumab treatment. (B) After the eculizumab treatment, the lesions gradually reduced until only the toes were involved, although a toe amputation was ultimately required.